Banque Cantonale Vaudoise Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

Banque Cantonale Vaudoise increased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 16,539.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,957 shares of the company’s stock after acquiring an additional 25,801 shares during the quarter. Banque Cantonale Vaudoise’s holdings in GE HealthCare Technologies were worth $1,849,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of GEHC. Laurel Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies during the fourth quarter worth about $26,000. Optima Capital LLC purchased a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at about $27,000. Godfrey Financial Associates Inc. acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at about $27,000. Montag A & Associates Inc. boosted its position in shares of GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC grew its stake in GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after buying an additional 262 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $65.76 on Friday. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a 50-day moving average price of $64.51 and a 200 day moving average price of $73.96. The company has a market cap of $29.91 billion, a P/E ratio of 15.73, a PEG ratio of 1.77 and a beta of 0.74. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

Insider Activity

In other GE HealthCare Technologies news, CFO James Saccaro acquired 3,310 shares of the business’s stock in a transaction on Friday, May 1st. The stock was purchased at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the transaction, the chief financial officer owned 87,471 shares of the company’s stock, valued at $5,300,742.60. The trade was a 3.93% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Rodney F. Hochman bought 1,618 shares of GE HealthCare Technologies stock in a transaction on Tuesday, May 12th. The stock was acquired at an average cost of $62.03 per share, with a total value of $100,364.54. Following the acquisition, the director owned 1,618 shares of the company’s stock, valued at $100,364.54. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 21,847 shares of company stock valued at $1,361,355 over the last three months. 0.36% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

GEHC has been the topic of several research analyst reports. The Goldman Sachs Group reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Jefferies Financial Group lowered their target price on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a report on Thursday, April 30th. Rothschild & Co Redburn reduced their price target on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. Finally, Mizuho decreased their price target on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $80.20.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.